Fibroblast proliferation pathway

"Fibroblast proliferation pathway" is not the name of a specific molecule, receptor, or canonical drug target. Instead, it refers to a broad biological process involving the signaling pathways and molecular mechanisms that regulate the proliferation of fibroblasts—cells critical for tissue repair and fibrosis. Multiple molecules and pathways can be involved in this process, such as growth factors (e.g., PDGF, TGF-beta), receptors (e.g., ERBB family), and downstream signaling cascades[2]. In cancer biology, targeting components of these pathways—such as inhibiting ERBB-mediated signals—can disrupt cancer-fibroblast interactions and control tumor growth[2]. However, "fibroblast proliferation pathway" itself is not a single molecular entity but rather an umbrella term for various interconnected targets. This entry is considered incorrect as a therapeutic target because it does not refer to one specific molecule or receptor but rather to an entire cellular process. For structured data extraction or drug discovery purposes, you would need to specify individual molecules within this pathway (such as "Platelet-derived growth factor receptor beta" or "Transforming growth factor beta receptor 1") instead of using this general term.